NIH-funded research R01 grant

Improving heart repair using specialized cell secretions

Official title: Maximizing Therapeutic Accumulation and Retention for Enhanced Cardiac Repair

Funded at Univ of North Carolina Chapel Hill · NIH-11056812 · Data updated 2026-11-12

This study is looking at a new way to help deliver tiny particles from stem cells to the heart after a heart attack, which could make it easier for patients to recover and improve heart function without needing invasive treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startMarch 15, 2024
Project endFebruary 28, 2028
Funding year2025
Award (this year)$623,558
NIH project number5R01HL174038-02
Project IDNIH-11056812 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced a myocardial infarction and are at risk of developing heart failure.

Less likely to help

Patients with non-ischemic heart conditions or those who have not experienced a heart attack may not benefit from this research.

What this research studies

This research focuses on enhancing the delivery of extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) to the heart after a heart attack. The goal is to overcome challenges related to the rapid diffusion and short retention of these therapeutic agents in the heart tissue. By developing a novel delivery strategy, the research aims to improve the accumulation of EVs in the damaged heart, potentially leading to better cardiac repair and function. Patients may benefit from a less invasive treatment option that could enhance recovery after myocardial infarction.

Why it matters

Potential benefit: If successful, this research could lead to improved heart repair and function for patients recovering from heart attacks.

How similar studies have gone: Previous research has shown promise in using extracellular vesicles for cardiac repair, but this approach aims to address significant delivery challenges that have not yet been overcome.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Nguyen, Juliane — Univ of North Carolina Chapel Hill
  • Study coordinator: Nguyen, Juliane

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.